Skip to content

Emotion-Cognition Interaction in Psychotic Disorders

Emotion-Cognition Interaction in Psychotic Disorders - E- CIPS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33944
Enrollment
120
Registered
2008-09-08
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis Schizophrenia

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with a diagnosis of *first episode psychosis* suggestive for the diagnosis schizophrenia are eligible to participate in the study. Age between 18 and 40 years. Patients may be inpatients or outpatients. Appearance of first symptoms not longer than 3 years ago.

Exclusion criteria

Exclusion criteria: Any other psychiatric or neurological diseases. Use of hard drugs as cocaine or heroin. Alcohol addiction. Subjects will also be excluded when they cannot understand the Dutch language sufficiently to understand the purposes and implications of the experiment.

Design outcomes

Primary

MeasureTime frame
• To investigate the interaction between cognitive capacities and emotional capacities in schizophrenia. • To investigate whether patients with schizophrenia differ from healthy controls in their selective attention and the influence of an affective component on selective attention function. • To investigate whether patients with schizophrenia differ from healthy controls in their working memory and the influence of an affective component on working memory function. • To investigate whether patients with schizophrenia differ from healthy controls in their long-term visual memory and the influence of an affective component on long-term visual memory function. • To investigate whether patients with schizophrenia differ from healthy controls in their long-term verbal memory and the influence of an affective component on long-term verbal memory function.

Secondary

MeasureTime frame
• To study whether there is an impact of pharmacological treatment and actual psychopathology on the interaction between cognitive capacities and emotional capacities in schizophrenia.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)